Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q21098912> ?p ?o }
Showing triples 1 to 29 of
29
with 100 triples per page.
- Q21098912 subject Q8661502.
- Q21098912 abstract "Serlopitant (VPD-737) is a drug which acts as an NK1 receptor antagonist. It was assessed in clinical trials for the treatment of urinary incontinence and overactive bladder, but while it was superior to placebo it provided no advantage over existing approved drugs, and was not approved for further development.".
- Q21098912 atcPrefix "none".
- Q21098912 casNumber "860642-69-9".
- Q21098912 iupacName "3-[(3aR,4R,5S,7aS)-5-{(1R)-1-[3,5-bis(Trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)-octahydro-2H-isoindol-2-yl]cyclopent-2-en-1-one".
- Q21098912 pubchem "23653789".
- Q21098912 thumbnail Serlopitant_structure.png?width=300.
- Q21098912 wikiPageWikiLink Q12744608.
- Q21098912 wikiPageWikiLink Q269829.
- Q21098912 wikiPageWikiLink Q281490.
- Q21098912 wikiPageWikiLink Q285166.
- Q21098912 wikiPageWikiLink Q30612.
- Q21098912 wikiPageWikiLink Q410943.
- Q21098912 wikiPageWikiLink Q426034.
- Q21098912 wikiPageWikiLink Q8386.
- Q21098912 wikiPageWikiLink Q8661502.
- Q21098912 wikiPageWikiLink Q874632.
- Q21098912 atcPrefix "none".
- Q21098912 casNumber "860642".
- Q21098912 iupacName "3".
- Q21098912 pubchem "23653789".
- Q21098912 type ChemicalSubstance.
- Q21098912 type Drug.
- Q21098912 type ChemicalObject.
- Q21098912 type Thing.
- Q21098912 type Q8386.
- Q21098912 comment "Serlopitant (VPD-737) is a drug which acts as an NK1 receptor antagonist. It was assessed in clinical trials for the treatment of urinary incontinence and overactive bladder, but while it was superior to placebo it provided no advantage over existing approved drugs, and was not approved for further development.".
- Q21098912 label "Serlopitant".
- Q21098912 depiction Serlopitant_structure.png.